Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

IBB vs NOBL: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, IBB returned +37.5% to NOBL's +15.5%, and NOBL charges 0.35% to IBB's 0.44%.

askIQ about this page

askIQ about IBB and NOBL

Net assets: $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF, and $11.6bn on Oct 28, 2026 for ProShares S&P 500 Dividend Aristocrats ETF.

At a glance
+37.5%
IBB total return, 1 year
+15.5%
NOBL total return, 1 year
0.44%
IBB expense ratio
0.35%
NOBL expense ratio

Pair scorecard

NOBL costs 0.09 points a year less; their one-year returns differ by 22.0 points; NOBL is 1.1 times larger.

IBB vs NOBL: Differences, Returns & Fees
MeasureIBBNOBL
Return
Total return, 1 year+37.5%+15.5%
Benchmark
What it tracksBiotechS&P 500 Dividend Aristocrats Index
Cost and size
Expense ratio0.44%0.35%
Net assets, as of Oct 27, 2026$11.0bn$11.7bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
Top ten holdings, share of the fund50%17.0%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, IBB and NOBL hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first IBB NOBL
Only in one fund ↓
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Only in NOBL
ROPER TECHNOLOGIES INC 1.81%
BECTON DICKINSON AND CO 1.78%
FACTSET RESEARCH SYSTEMS INC 1.77%
INTL BUSINESS MACHINES CORP 1.70%
AUTOMATIC DATA PROCESSING 1.69%
EMERSON ELECTRIC CO 1.67%
CHEVRON CORP 1.66%
ERIE INDEMNITY COMPANY-CL A 1.64%
Check overlap with more funds →

Side by side

IBB iShares Biotechnology ETF NOBL ProShares S&P 500 Dividend Aristocrats ETF
Where it sits Thematic ETF Stock ETF
What it is Biotech Tracks the S&P 500 Dividend Aristocrats
Total return, 1 year +37.5% +15.5%
Expense ratio 0.44% 0.35%
Already in the S&P 500 40.2% 98.3%
Holdings 245 69
Net assets, IBB as of Oct 27, 2026 and NOBL as of Oct 28, 2026 $11.0bn $11.6bn

IBB and NOBL on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

IBB and NOBL flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

NOBL

NOBL tracks the S&P 500 Dividend Aristocrats. Over the year to Oct 28, 2026 it returned +15.5% with distributions reinvested. The prospectus expense ratio is 0.35% a year. By its holdings published by its issuer for Oct 27, 2026, 98% of the fund by weight is stocks the S&P 500 also holds, across 69 positions, with the top ten at 17.0%.

Questions people ask

Are IBB and NOBL in the same category?
IBB is a thematic ETF and NOBL is a stock ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, IBB or NOBL?
In the year to Oct 28, 2026, with distributions reinvested, IBB returned +37.5% and NOBL +15.5%.
Which is cheaper, IBB or NOBL?
NOBL is cheaper, by 0.09 percentage points a year. That is about $9 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do IBB and NOBL overlap with the S&P 500?
By their latest filed holdings, 40% of IBB and 98% of NOBL by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, IBB against NOBL, data as of Oct 28, 2026. https://etfiq.com/compare/any/ibb-vs-nobl

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.